Toward quantification of hypoxia using fluorinated Eu(II/III)-containing ratiometric probes

Hypoxia is a prognostic biomarker of rapidly growing cancers, where the extent of hypoxia is an indication of tumor progression and prognosis; therefore, hypoxia is also used for staging while performing chemo- and radiotherapeutics for cancer. Contrast-enhanced MRI using Eu(II)-based contrast agent...

Descripción completa

Detalles Bibliográficos
Autores principales: Subasinghe, S. A. Amali S., Ortiz, Caitlyn J., Romero, Jonathan, Ward, Cassandra L., Sertage, Alexander G., Kurenbekova, Lyazat, Yustein, Jason T., Pautler, Robia G., Allen, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2023
Materias:
Physical Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104500/
https://www.ncbi.nlm.nih.gov/pubmed/37018203
http://dx.doi.org/10.1073/pnas.2220891120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104500/
https://www.ncbi.nlm.nih.gov/pubmed/37018203
http://dx.doi.org/10.1073/pnas.2220891120

Ejemplares similares